Brain connectivity found to be disrupted in schizophrenia

byElsevierBrain areas with the greatest difference between individuals with and without schizophrenia, with a pronounced negative effect in visual areas of the brain. Credit:Biological Psy

Updated on: January 11,2024

Brain connectivity found to be disrupted in schizophrenia

byElsevierBrain areas with the greatest difference between individuals with and without schizophrenia, with a pronounced negative effect in visual areas of the brain. Credit:Biological Psy

Updated on:January 11,2024

Dial for tuning dopamine, environmental signals found in Parkinson's

by University of Alabama in TuscaloosaC. elegans, seen here as hundreds living on a plate viewed through the lens of a microscope, share roughly half their genes with humans. Credit: The Universi

Updated on: February 05,2024

Dial for tuning dopamine, environmental signals found in Parkinson's

by University of Alabama in TuscaloosaC. elegans, seen here as hundreds living on a plate viewed through the lens of a microscope, share roughly half their genes with humans. Credit: The Universi

Updated on:February 05,2024

Devastating causes of childhood dementia revealed

by Jessica Stanley,University of AdelaideOverall survival of the cohort born with currently untreatable childhood dementia. Credit:Brain(2023). DOI: 10.1093/brain/awad242It is a hear

Updated on: March 02,2024

Devastating causes of childhood dementia revealed

by Jessica Stanley,University of AdelaideOverall survival of the cohort born with currently untreatable childhood dementia. Credit:Brain(2023). DOI: 10.1093/brain/awad242It is a hear

Updated on:March 02,2024

Study finds increased risk of Guillain-Barré after COVID-19 infection

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainHaving a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome w

Updated on: January 11,2024

Study finds increased risk of Guillain-Barré after COVID-19 infection

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainHaving a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome w

Updated on:January 11,2024

Manipulating light can induce psychedelic experiences—and scientists aren't quite sure why

by Matthew MacKisack and Reshanne Reeder,The ConversationFrom Jan E. Purkinje’s documentation of the subjective visual phenomena he saw when he waved his hand in front of his closed eyes. Author

Updated on: February 05,2024

Manipulating light can induce psychedelic experiences—and scientists aren't quite sure why

by Matthew MacKisack and Reshanne Reeder,The ConversationFrom Jan E. Purkinje’s documentation of the subjective visual phenomena he saw when he waved his hand in front of his closed eyes. Author

Updated on:February 05,2024

Organoids reveal an overlooked protein's role in traumatic brain injury

by Cell PressOrganoid with neurons labeled in green. Credit: Josh BerlindClinicians often find limited success in treating patients with traumatic brain injury, a condition long linked to contact

Updated on: April 06,2024

Organoids reveal an overlooked protein's role in traumatic brain injury

by Cell PressOrganoid with neurons labeled in green. Credit: Josh BerlindClinicians often find limited success in treating patients with traumatic brain injury, a condition long linked to contact

Updated on:April 06,2024

Team presents new approach to discover targets for Alzheimer's, other diseases with protein phase separation

by InSilico MedicinePET scan of a human brain with Alzheimer's disease. Credit: public domainRecent research demonstrates that protein phase separation (PPS) is widely present in cells and drives

Updated on: January 07,2024

Team presents new approach to discover targets for Alzheimer's, other diseases with protein phase separation

by InSilico MedicinePET scan of a human brain with Alzheimer's disease. Credit: public domainRecent research demonstrates that protein phase separation (PPS) is widely present in cells and drives

Updated on:January 07,2024

Insights on FDA's controversial approval of Alzheimer's drug

by Patrick Ercolano,Johns Hopkins UniversitySupriya Munshaw. Credit: Johns Hopkins UniversityThe U.S. Food and Drug Administration's recent approval of aducanumab, a treatment for Alzheimer&

Updated on: May 22,2024

Insights on FDA's controversial approval of Alzheimer's drug

by Patrick Ercolano,Johns Hopkins UniversitySupriya Munshaw. Credit: Johns Hopkins UniversityThe U.S. Food and Drug Administration's recent approval of aducanumab, a treatment for Alzheimer&

Updated on:May 22,2024

A devastating nerve disease stalks a mountain village

Updated on: December 30,2024

A devastating nerve disease stalks a mountain village

Updated on:December 30,2024

Interfering with antiviral pathway may deter Alzheimer's disease and frontotemporal dementia

by Weill Cornell Medical CollegeThe cGAS–STING pathway is activated in the hippocampi of mice with tauopathy and in human AD brains. Credit:Nature Neuroscience(2023). DOI: 10.1038/s41

Updated on: June 04,2024

Interfering with antiviral pathway may deter Alzheimer's disease and frontotemporal dementia

by Weill Cornell Medical CollegeThe cGAS–STING pathway is activated in the hippocampi of mice with tauopathy and in human AD brains. Credit:Nature Neuroscience(2023). DOI: 10.1038/s41

Updated on:June 04,2024

Research overturns previous findings on potential Parkinson's disease target

JANUARY 22, 2024byWalter and Eliza Hall Institute of Medical ResearchDetermining nucleotide-bound PhPINK1 structures. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adj7408A new

Updated on: March 28,2024

Research overturns previous findings on potential Parkinson's disease target

JANUARY 22, 2024byWalter and Eliza Hall Institute of Medical ResearchDetermining nucleotide-bound PhPINK1 structures. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adj7408A new

Updated on:March 28,2024

A TREM2 activating antibody with a transport vehicle that could boost the metabolism and function of brain microglia

by Ingrid Fadelli , Medical XpressImages showing the architecture of our ATV:TREM2 molecule (a) images showing elevation of microglia proliferation in the brain of mice treated with ATV:TREM2 (b) a su

Updated on: March 26,2024

A TREM2 activating antibody with a transport vehicle that could boost the metabolism and function of brain microglia

by Ingrid Fadelli , Medical XpressImages showing the architecture of our ATV:TREM2 molecule (a) images showing elevation of microglia proliferation in the brain of mice treated with ATV:TREM2 (b) a su

Updated on:March 26,2024